We would love to hear your thoughts about our site and services, please take our survey here.
Indeed. There have been great opportunities for big ball players to gain profits and come back and probably continue to be so, but it is a massive gamble as covgaz hinted. If you have the will and courage to try then go for it, but many wont (similarly to myself) as losing sleep for ??? amount of time isn't worth it.
are*
"Aww shieet, here we go again". I'd say late drops are part of the bigger panic caused by some Japanese Nasdaq tech stock players. This has caused drops across the line everywhere. A volatile stock like Faron that has been targeted by quick buck traders can quickly follow these moves without any sensible cause. Again, patient investors is still on the way to (the same) positive outcome.
Even, if it was, it is just a one patient, one case. Every day things seem to go more and more hyper in the media. While I have my reservations about the academia and especially the pharma side of it, they are miles more reasonable than mainstream media and social media who are mainly after clicks. Strange times indeed when one few word tweet can cause movements of two digits in stock prices. Look for statistical significance, ignore hype and drivel (if you like consistency).
Today's drop is a classic kneejerk reaction of trader types because of 'news'. I would not put much weigh on that when making my decisions regarding this paper. It's literally nothing. If this movement gave -you- cold sweat, I'd point you towards all the research revealed here and elsewhere, as you haven't likely familiarized yourself with the history of the company. The facts are there and they will likely induce calmness rather than anxiety.
Now is the time to buy, if you still want in.
Those with minimal homework left, we wait, we wait, with great patience we wait.
No wonder as the 5€ mark got broken in Helsinki.
Many are still lurking in the shadows. If one came to Farn, it would require some immense stunts to lose that cemented faith. Only a spectacular case of amnesia would be able to argument against all the posted facts.
That's the same but now in another magazine
To be more precise "melkein maalissa" would more closely translate to "almost at the goal" rather than "almost finished". "Melkein maalissa" carries a strong positive connotation (in a future sense); a sign of relief to come. Still, sometimes, if "melkein maalissa" is used in a past sense it carries a negative aspect; "he was almost at the goal but then X happened". Good thing the article is looking forward, and we are too! ;)
Long9, please elaborate why? Based exactly on what facts? The share price (wtf)?
My two quick cents. On the financial side not much will happen until (again) the Nasdaq and AIM prices meet, and Lago & co. are at work. This seems to be futile, though, as AIM does not want to rise and Nasdaq has plenty of buying pressure, so the price always goes back up from the small dips. On the other side.. it's just a waiting game. Investors want results from the trials, patients want results from the trials etc.; the whole market is anxiously waiting for results from all of these trials as we can see from yesterday's situation in the Western marketplaces, especially Europe.
Faron again represented on one of the Finnish financial news site (one which I value, too). It is one of the first ones in Finnish (that I've seen) where Faron has been treated as a company, and not just a topic of superlative journalism. Inderes, one of the more known Finnish entities giving market analyses (on a very broad axis) has apparently given Faron a target price of 5,56 euros (I did not know Faron was under market analysis here). Article in Finnish, though. Bargain bin times might be over.
https://www.arvopaperi.fi/uutiset/faron-tuo-houkuttelevaa-riskikerrointa-sijoitussalkkuun-yhtion-laake-mukana-selvityksessa-kahdessa-eri-koronatutkimuksessa/6d392a12-369e-4fe6-bc2e-10f659eb5208
Not long and everyone knows what interferons are.
Guess I'll just buy more then.
Greenman, IFN-beta 1-alpha is literally the same than IFN-beta 1-beta with a single tiny difference in the protein (/chemical) structure. When one of the cysteines (no. 17) in the amino acid sequence of the IFN-beta 1a is replaced by serine, we call that IFN-beta 1b. I'm pretty sure it has no effect on the functionality of the interferon protein. As a side note, the 1a is equivalent to the human IFN-beta.
It is relieving to hear that my overeducated lump of neurons is actually of use for someone for once. :'D
Sax, that is the difference between so called 'classical' drugs and engineered drugs. These days a symptom/issue is recognized (/made up) and big data means (of molecular biotechnology) are used to recognize substances that affect it in a 'positive' way (also often made up - Can one say about many drugs that the desirable effect overcomes the side effects on average? Not really). This group is gradually reduced in size until zero or more drugs are on the shelves; rinse and repeat. The engineering aspect of the symptom/issue and then the substance allows a very deep knowledge about how the substance actually functions in a biomechanical way (around the symptom/issue, at least - again look at all the side effects). Classically some positive effect of a substance/natural product was recognized by chance and then this effect was utilized (it was obviously easier decades ago when modern medicine was making its first steps). Due to the complicated nature of the functions of many substances in our system, many are still shrouded in partial mystery, even after decades of rigorous research (look at nitroglycerin, for example). This 'mystery' aspect is why modern medical experts usually shun on natural medicinal products. It is a bit hypocritical, though, as drug companies have throughout the years patented and monetized engineered versions of these same natural extracts with gigantic profits.
Also, to not go completely off topic; IV-version of IFN-beta 1a is going to be so much more efficacious when compared to the subcutaneous version it's almost funny, if it weren't such a serious topic. Just wait for the Solidarity results.
I've had the exact same questions as you Sax.